Back to Agenda
WHO Town Hall: Safeguarding Public Health - WHO's Vision for Global Regulatory Excellence
Session Chair(s)
Samvel Azatyan, MD, PHD
Senior Adviser, Council For International Organizations of Medical Sciences (CIOMS), Switzerland
This session aims to delve into WHO's pivotal role in the evolving landscape of global regulatory excellence. The discussion will revolve around the transformative impact of WHO-listed Authorities on medical product regulation, emphasizing regulatory reliance as a holistic approach to enhance efficiency and accessibility. Additionally, the session will address the pressing issue of substandard/falsified medical products and their potential threats to global health.
Learning Objective : Describe the significance of WHO-listed Authorities in shaping the future of medical product regulation; Examine the concept of regulatory reliance as a key strategy to enhance access and efficiency in global regulatory practices; Discuss the critical role of regulatory excellence in safeguarding public health against the threats posed by substandard/falsified medical products.
Speaker(s)
Elevating Regulatory Reliance: The Strategic Impact of WHO-Listed Authorities in Transforming Global Regulatory Landscapes
Unit Head, Regulation and Safety, Department of Regulation and Prequalification, World Health Organization (WHO), Switzerland
Securing Supply Chains: A Global Imperative
Team Lead, Incidents and Substandard/Falsified Medical Products, World Health Organization (WHO), Switzerland
EMA Update
Chair, ICMRA; Executive Director, European Medicines Agency, Netherlands
Industry Update
Director, Scientific and Regulatory Affairs, IFPMA, Switzerland
Moderator for Panel Discussion and Q&A
Technical Officer, Regulatory Convergence and Networks, World Health Organization (WHO), Switzerland
Have an account?